Analytical Testing

Pharmaceutical Outsourcing Analytical Testing - Laptop Showing Data

Analytical testing services outsourcing allows pharmaceutical innovator companies to handle more complex tasks in-house while also assisting companies in concentrating on their core competencies, enabling pharmaceutical companies to avoid developing specialized facilities and hiring staff, results in cost savings.

Specifically, pharmaceutical analytical testing refers to quantifying and identifying components in pharmaceutical drugs and solutions. The goal is to ensure products meet FDA regulations for safety, potency, purity, and stability.

Analytical development and testing services may also include method development, method transfers, qualification and validation services.

Filter

Hide Filter

  • Anticipating Future Guidelines By Utilizing The Latest Technologies In Particle Characterization

    Friday, March 17, 2017
    The presence of particulate matter in pharmaceutical products con-tinues to be one of the top reasons for recall. This year, 11 of the 54 safety alerts issued by the FDA were for the presence of particulates in drug and therapeutic biological ... read more

  • Stay Tuned: Pharma’s Almanac TV Goes Live

    Wednesday, March 15, 2017
    If you were at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Denver in November, you surely would not have missed the That’s Nice booth. There was a large company team, pop art imagery, the opportunity to stand ... read more

  • Equipment Must Integrate

    Wednesday, March 15, 2017
    Modern pharmaceutical manufacturing equipment and associated analytical instrumentation is the fundamental ‘hardware’ required to produce safe, effective, highquality medicinal products. To meet the challenges from increasingly downward price ... read more

  • Advancing Solid Dose Processing Efficiency and Effectiveness

    Wednesday, March 15, 2017
    Because oral solid dose (OSD) pharmaceuticals will remain the dominant dose form, the pharmaceutical industry will continue to be responsible for the high-quality manufacture of hundreds of millions of individual doses every day, every year ... read more

  • Expanding the Commercial Options for Preparation of Amorphous Solid Dispersions

    Wednesday, March 15, 2017
    Solubility in physiological fluids is a prerequisite for high bioavailability of drug substances. For many APIs that exhibit poor water solubility, bioavailability can be enhanced by preparing the product in an amorphous rather than a crystalline ... read more

  • Achieving Security of Supply with Effective Particle Engineering

    Wednesday, March 15, 2017
    Targeted particle engineering for solid dosage drug formulations has become an imperative given the challenging compounds in the pharmaceutical pipeline, the growing interest in inhaled delivery, and the move to continuous manufacturing. Contract ... read more

  • Spending on Excipients Grows & Diversifies

    Wednesday, March 15, 2017
    Pharmaceutical excipients are used in combination with APIs in multiple medicinal products, including tablets, capsules, oral liquids, transdermal patches, implants and inhalers. Traditionally, these excipients were used to add bulk to ... read more

  • New Ventures In The Microbiome

    Wednesday, March 15, 2017
    The human body harbors up to 100 trillion microbial organisms throughout the gut, skin, oral cavity, respiratory system and urogenital tract, among other organs and systems. Collectively these microorganisms are known as the microbiota, and ... read more

  • Cloud Computing.. Roundtable

    Wednesday, March 15, 2017
    What impact do you think the move to cloud computing will have on the ability of contract service organizations to better QQ meet the needs of their customers? read more

  • Changes In the Wind for the CDMO Market

    Wednesday, March 15, 2017
    The global pharmaceutical market continues to grow at a healthy rate. According to research firm Evaluate Pharma, the global drug market will expand at a compound annual growth rate (CAGR) of 6.3% from 2016 to 2022, with biologics accounting for ... read more

  • The Data Generation

    Wednesday, March 15, 2017
    The first issue of Pharma’s Almanac in 2017 explores the current market landscape and the impact of Big Data and covers a whole host of other topics: read more

  • Spending on Contract Research Services Slowing Down

    Wednesday, March 15, 2017
    The 2017 Nice Insight Clinical Research Organization (CRO) Outsourcing Survey1 includes input from 608 outsourcing-facing pharmaceutical and biotechnology executives. The majority of the respondents are key decision makers; nearly one-third (31%)... read more

  • Enhancing Responsiveness with Embedded Flexibility

    Wednesday, March 15, 2017
    Responsiveness has always been a key expectation for contract manufacturers providing services to the pharmaceutical industry. Today, however, with increased competition, the growing importance of evidence-based medicine, the expanding focus on ... read more

  • Next-Generation OSD Manufacturing Strategy

    Wednesday, March 15, 2017
    The Facility of the Future has to be more agile, flexible and efficient than it is today. How to get there? By innovating — introducing new processing concepts, analytics and control — and pulling it together with attention to flow and ergonomics... read more

  • Dissolving Boundaries In Worldwide Clinical Trial Logistics for Biological Samples and New Therapies

    Wednesday, March 15, 2017
    Marken is a leading patient-centric supply chain logistics organization with a complete focus on the pharmaceutical and life-sciences industries. Its state-ofthe- art GMP-compliant network includes 10 GMP-compliant depots and 45 worldwide logistic ... read more
Page